{
  "nctId": "NCT04913948",
  "briefTitle": "Assessing the Mother-to-infant Transmission Capabilities of COVID-19 Infection Among Pregnant Women in Ontario, Canada",
  "officialTitle": "Assessing the Mother-to-infant Transmission Capabilities of COVID-19 Infection Among Pregnant Women in Ontario, Canada",
  "protocolDocument": {
    "nctId": "NCT04913948",
    "filename": "Prot_SAP_000.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2024-11-15",
    "uploadDate": "2024-11-22T12:30",
    "size": 690747,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT04913948/document/Prot_SAP_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [],
  "studyType": "OBSERVATIONAL",
  "enrollmentInfo": {
    "enrollmentCount": 246,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2020-04-30",
    "completionDate": "2021-07-31",
    "primaryCompletionDate": "2021-07-31",
    "firstSubmitDate": "2021-03-03",
    "firstPostDate": "2021-06-04"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Pregnant women with confirmed COVID-19 at any point during pregnancy or suspected COVID-19 at time of delivery (as identified at local hospital) , who will be delivering at a participating hospital in Ontario or Quebec\n\nExclusion Criteria:\n\n* None",
    "healthyVolunteers": false,
    "sex": "FEMALE",
    "stdAges": [
      "CHILD",
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Rate of Perinatal Transmission of SARS-CoV-2",
        "description": "Evidence of SARS-CoV-2 RNA or antibodies against SARS-CoV-2 from a sterile (amniotic fluid) or non-sterile sample (nasopharyngeal swab sample, placental tissue, subamniotic swab or by cord blood serology \\[for IgM or IgA\\]) collected during the maternal hospital admission for delivery (specific time frame varied per participant).",
        "timeFrame": "During the delivery admission"
      },
      {
        "measure": "Rate of Intrauterine Transmission of SARS-CoV-2",
        "description": "Evidence of SARS-CoV-2 RNA or antibodies against SARS-CoV-2 in fetal tissues (i.e., amniotic fluid, placental tissue, sub-amniotic swab, cord blood) collected during maternal hospital admission for delivery (specific time frame varied per participant). Evidence of intrauterine transmission was determined using RT-PCR and serological analysis.",
        "timeFrame": "During the delivery admission"
      }
    ],
    "secondary": [],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 2,
      "secondaryCount": 0,
      "otherCount": 0,
      "totalCount": 2
    },
    "studyDesign": {
      "phases": [],
      "isRandomized": false,
      "isMasked": true
    },
    "overallComplexityScore": 39,
    "complexityCategory": "Moderate"
  },
  "collectionDate": "2025-09-22T02:30:38.626Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}